Exploring the glucose-lowering and anti-inflammatory immune mechanism of artemether by AMPK/mTOR pathway and microbiome based on multi-omics.

Front Pharmacol · 2025 · PMC11879814 · PMID 40046742

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Moreover, the expression of p-mTOR, p-P38, p-IKBα, p-IRS1, TLR4 showed an increasing trend without no significant difference among three groups ( Supplementary Figures S3A–E ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.